Genomic imbalances in human leukemia and lymphoma detected by comparative genomic hybridization (Review)

International Journal of Oncology

Volumn 27, Issue 3, 2005, Pages 593-606

  Gebhart, Erich ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Genomic hybridization; Leukemia; Lymphoma

Indexed keywords

CHROMOSOME ABERRATION; COMPARATIVE STUDY; GENETICS; GENOME; HUMAN; LEUKEMIA; LYMPHOMA; METHODOLOGY; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY; REVIEW;

CHROMOSOME ABERRATIONS; GENOME, HUMAN; HUMANS; LEUKEMIA; LYMPHOMA; NUCLEIC ACID HYBRIDIZATION;

EID: 24344436410     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Review

References (148)

1. Gebhart E: Comparative genomic hybridization (CGH): ten years of substantial progress in human solid tumor molecular genetics. Cytogenet Genome Res 104: 352-358, 2004.
2. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821,1992.
3. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman F, Gray JW and Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10: 231-243, 1994.
4. Jeuken JWM, Sprenger SHE and Wesseling P: Comparative genomic hybridization: practical guidelines. Diag Mol Pathol 11: 193-203,2002.
5. Wolff E, Girod S, Liehr T, Vorderwulbecke U, Ries J, Steininger H and Gebhart E: Oral squamous cell carcinomas are characterized by a rather uniform pattern of genomic imbalances detetcted by comparative genomic hybridization. EurJ Cancer 34: 186-190, 1998.
6. Du Manoir S, Kallioniemi OP, Lichter P, Piper J, Benedetti BA, Carothers AD, Fantes JA, Garcia-Sagredo JM, Gerdes T, Giollant M, Hemery B, Isola J, Maahr J, Morrison H, Perry P, Stark M, Sudar D, van Vliet LJ, Verwoerd N and Vrolijk J: Hardware and software requirements for quantitative analysis of comparative genomic hybridization. Cytometry 19: 4-9, 1995.
7. Lundsteen C, Maahr J, Christensen B, Bryndorf T, Bentz M, Lichter P and Gerdes T: Image analysis in comparative genomic hybridization. Cytometry 19: 42-50, 1995.
8. Kirchhoff M, Gerdes T, Rose H, Maahr J, Ottesen AM and Lundsteen C: Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals. Cytometry 31: 163-173, 1998.
9. Karhu R, Rummukainen J, Lörch T and Isola J: Four-color CGH: a new method for quality control of comparative genomic hybridisation. Genes Chromosomes Cancer 24: 112-118, 1999.
10. Barth TFE, Benner A, Bentz M, Döhner H, Möller P and Lichter P: Risk of false positive results in comparative genomic hybridization. Genes Chromosomes Cancer 28: 353-357, 2000.
11. Bentz M, Plesch A, Stilgenbauer S, Döhner H and Lichter P: Minimal size of deletions detected by comparative genomic hybridization. Genes Chromosomes Cancer 21: 172-175, 1998.
12. Brecevic L, Verdorfer I, Saul W, Trautmann U and Gebhart E: The cytogenetic view of standard comparative genomic hybridization (CGH): deletions of 20q in human leukemia as a measure of the senitivity of the technique. Anticancer Res 21: 89-92,2001.
13. Kirchhoff M, Gerdes T, Maahr J, Rose H, Bentz M, Döhner H and Lundsteen C: Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervals. Genes Chromosomes Cancer 25: 410-413, 1999.
14. Gebhart E, Verdorfer I, Saul W, Trautmann U and Brecevic L: Delimiting the use of comparative genomic hybridization in human myeloid neoplastic disorders. Int J Oncol 16: 1099-1105, 2000.
15. Larsen J, Kirchhoff M, Rose H, Gerdes T, Lundsteen C and Larsen JK: Improved sensitivity in comparative genomic hybridisation analysis of DNA heteroploid cell mixtures after pre-enrichment of subpopulations by fluorescence activated cell sorting. Anal Cell Pathol 19: 119-124, 1999.
16. Wilkens L, Tchinda J, Burkhardt D, Nolte M, Werner M and Georgii A: Analysis of hematologic diseases using conventional karyotyping, fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH). Hum Pathol 29: 833-839,1998.
17. Bayerlein K, Rith T, Verdorfer I, Liehr T, Wolff E, Girod S and Gebhart E: I-FISH control of CGH-detected gain of DNA sequence copy number in oral squamous cell carcinoma (OSCC). Anticancer Res 20: 427-432, 2000.
18. Du Manoir S, Speicher MR, Joos S, Schröck E, Popp S, Döhner H, Kovacs G, Robert-Nicoud M, Lichter P and Cremer T: Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridisation. Hum Genet 90: 590-610, 1993.
19. Bentz M, Döhner H, Huck K, Schutz B, Ganser A, Joos S, Du Manoir S and Lichter P: Comparative genomic hybridization in the investigation of myeloid leukemias. Genes Chromosomes Cancer 12: 193-200, 1995.
20. Bentz M, Huck K, Du Manoir S, Joos S, Werner CA, Fischer K, Döhner H and Lichter P: Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood 85: 3610-3618, 1995.
21. Nacheva E, Grace C, Holloway TL and Green AR: Comparative genomic hybridization in acute myeloid leukemia. Cancer Genet Cytogenet 82: 9-16, 1995.
22. Starke H, Raida M, Trifonov V, Clement JH, Loncarevic IF, Heller A, Bleck C, Nietzel A, Rubtsov N, Claussen U and Liehr T: Molecular genetic characterization of an acquired minute supernumerary marker chromosome as the sole abnormality in a case of clinically diagnosed as atypical Philadelphia-negative chronic myelogenous leukaemia. Br J Hematol 113: 435-438, 2001.
23. Gribble SM, Sinclair PB, Grace C, Green AR and Nacheva EP: Comparative analysis of G-banding, chromosome painting, locusspecific fluorescence in situ hybridization, and comparative genomic hybridization in chronic myeloid leukemia blast crisis. Cancer Genet Cytogenet 111:7-17,1999.
24. Gribble SM, Reid AG, Roberts I, Grace C, Green AR and Nacheva EP: Genomic imbalances in CML blast crisis: 8q24.12-q24.13 segment identified as a common region of overrepresentation. Genes Chromosomes Cancer 37: 346-358, 2003.
25. Herishanu Y, Lishner M, Bomstein Y, Kitay-Cohen Y, Fejgin MD, Gaber E and Amiel A: Comparative genomic hybridisation in polycythemia vera and essential thrombocytosis patients. Cancer Genet Cytogenet 128: 154-157, 2001.
26. Wilkens L, Burkhardt D, Tchinda J, Biische G, Wener M, Nolte M, Ganser A and Georgii A: Cytogenetic aberrations in myelodysplastic syndrome detected by comparative genomic hybridization and fluorescence in situ hybridization. Diagn Mol Pathol 8: 47-53, 1999.
27. Castuma MV, Rao PH, Acevedo SH and Larripa IB: Comparative genomic hybridization study of de novo myeloid neoplasia. Acta Haematol 104:25-30, 2000.
28. Martinez-Ramirez A, Urioste M, Melchor L, Blesa D, Valle L, Alvarez de Andres S, Kok K, Calasanz MJ, Cigudosa JC and Benitez J: Analysis of myelodysplastic syndromes with complex karyotypes by high-resolution comparative genomic hybridization and subtelomeric CGH array. Genes Chromosomes Cancer 42: 287-298, 2005.
29. El-Rifai W, Elonen E, Larramendy M, Ruutu T and Knuutila S: Chromosomal breakpoints and changes in DNA copy number in refractory acute myeloid leukemia. Leukemia 11: 958-963, 1997.
30. Huhta T, Vettenranta K, Heinonen K, Kanerva J, Larramendy ML, Mahlamäki E, Saarinen-Pihkala UM and Knuutila S: Comparative genomic hybridization and conventional cytogenetic analyses in childhood acute myeloid leukemia. Leuk Lymphoma 35: 311-315,1999.
31. Kim MH, Stewart J, Devlin C, Kim YT, Boyd E and Connor M: The application of comparative genomic hybridization as an additional tool in the chromosome analysis of acute myeloid leukemia and myelodysplastic syndromes. Cancer Genet Cytogenet 126:26-33, 2002.
32. Casas S, Aventin A, Fuentes F, Vallespi T, Granada I, Carrio A, Martinez-Climent JA, Sole F, Teixeido M, Bernues M, Duarte J, Hernandez JM, Brunet S, Coll MD and Sierra J: Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia. Cancer Genet Cytogenet 153: 16-25, 2004.
33. Willem P and Mendelow B: 12p rearrangement and DNA amplification mapped by comparative genomic hybridization in a patient with secondary myeloid leukemia. Cancer Genet Cytogenet 99: 30-37,1997.
34. Kocki J, Constantinou M, Cioch M, Lancut M, Kaluzewski B, Dmoszynska A and Wojcierowski J: Molecular diagnostics of promyelocytic leukaemia. J Appl Genet 44: 553-556, 2003.
35. Verdorfer I, Brecevic K, Saul W, Schenker B, Kirsch M, Traitmann U, Helm G, Gramatzki M and Gebhart E: Comparative genomic hybridization-aided unravelling of complex karyotypes in human hematopoietic neoplasias. Cancer Genet Cytogenet 124:1-6,2001.
36. Heller A, Chudoba I, Bleck C, Senger G, Claussen U and Liehr T: Microdissection based comparative genomic hybridization analysis (micro-CGH) of secundary acute myelogenous leukemias. Int J Oncol 16: 461-468, 2000.
37. Haas OA, Henn T, Romanakis K, Du Manoir S and Lengauer C: Comparative genomic hybridization as a part of a new diagnostic strategy in childhood hyperdiploid acute lymphoblastic leukemia. Leukemia 12:474-481, 1990.
38. Jarasova M, Holzerova M, Jedlickova K, Mihal V, Zuna J, Stary J, Pospisilova D, Zemanova Z, Trka J, Blazek J, Pikalova Z and Indrak K: Importance of using comparative genomic hybridization to improve detection of chromosomal changes in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 123: 114-122,2000.
39. Karhu R, Siitonen S, Tanner M, Keinänen M, Mäkipernaa A, Lehtinen M, Vilpo JA and Isola J: Genetic aberrations in pediatric acute lymphoblastic leukemia by comparative genomic hybridization. Cancer Genet Cytogenet 95: 123-129, 1997.
40. Kristensen TD, Wesenberg F, Jonsson OG, Carlsen NT, Forestier E, Kirchhoff M, Lundsteen C and Schmiegelow K: High-resolution comparative genomic hybridisation yields a high detection rate of chromosomal aberrations in childhood acute lymphoblystic leukaemia. Eur J Haematol 70: 363-372, 2003.
41. Larramendy ML, Huhta T, Heinonen K, Vettenranta K, Mahlamäki E, Riikonen P, Saarinen-Pihkala UM and Knuutila S: DNA copy number changes in childhood acute lymphoblastic leukemia. Haematologia 83: 890-895, 1998.
42. Paszek-Vigier M, Talmant P. Mechinaud F, Garand R, Harousseau JL, Bataille R and Avet-Loiseau H: Comparative genomic hybridization is a powerful tool, complementary to cytogenetics, to identify chromosomal abnormalities in childhood acute lymphoblastic leukaemia. Br J Haematol 99: 589-596. 1997.
43. Kanerva J, Niini T, Vettenranta K, Riikonen P, Mäkipernaa A, Karhu R, Knuutila S and Saarinen-Pihkjala UM: Loss at 12p detected by comparative genomic hybridization (CGH): association with TEL-AML1 fusion and favorable prognostic features in childhood acute lymphoblastic leukemia (ALL). A multi-institutional study. Med Pediatr Oncol 37: 419-425, 2001.
44. Scholz I, Popp S, Granzow M, Schoell B, Holtgreve-Grez H, Takeuchi S, Schrappe M, Harbott J, Teigler-Schlegel A, Zimmermann M. Fischer C, Koeffler HP, Bartram CR and Jauch A: Comparative genomic hybridization in childhood acute lymphoblastic leukemia: correlation with interphase cytogenetics and loss of heterozygosity analysis. Cancer Genet Cytogenet 124:89-97, 2001.
45. Wong N, Chen SJ, Cao Q, Su XY, Niu C, Wu QW, Leung TWT, Wickham N, Johnson PJ and Chen Z: Detection of chromosome over- and under-representations in hyperdiploid acute lymphoblastic leukemia by comparative genomic hybridization. Cancer Genet Cytogenet 103: 20-24, 1998.
46. Larramendy ML, Huhta T, Vettenranta K, El-Rifai W, Lundin J, Pakkala S, Saarinen-Pihkala UM and Knuutila S: Comparative genomic hybridization in childhood acute lymphoblastic leukemia. Leukemia 12: 1638-1644, 1998.
47. Tsukasaki K, Krebs J, Nagai K, Tomonaga M, Koeffler HP, Bartram CR and Jauch A: Comparative genomic hybridization analysis in adult T-cell' leukemia/lymphoma: correlation with clinical course. Blood 97: 3875-3881, 2001.
48. Tsukasaki K: Genetic instability of adult T-cell leukemia/lymphoma by comparative genomic hybridization analysis. J Clin Immunol 22: 57-63, 2002.
49. Ariyama Y, Mori T, Shinomiya T, Sakabe T, Fukuda Y, Kanamary A, Yamada Y, Isobe M, Seto M, Nakamura Y and Inazawa J: Chromosomal imbalances in adult T-cell leukemia revealed by comparative genomic hybridization: gains at 14q32 and 2p16-22 in cell lines. J Hum Genet 44: 357-363, 1999.
50. Gebhart E, Thoina K, Verdorfer I, Drexler HG and Efferth T: Genomic imbalances in T-cell acute lymphoblastic leukemia cell lines. Int J Oncol 21: 887-894, 2002.
51. Bea S, Lopez-Guillermo A, Ribas M, Puig X, Pinyol M, Carrion A, Zamora L, Soler F, Bosch F, Stilgenbauer S, Colomcr D, Miro R, Montserrat E and Campo E: Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome) Am J Pathol 161:957-968,2002.
52. Ottaggio L, Viaggi S, Zunino A, Zupo S, Rossi E, Spriano M, Abbondandolo A and Ferrarini M: Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression. Haematologica 88: 769-777, 2003.
53. Karhu R, Tobin G, Thunberg U, Vilpo L, Sundström C, Knuutila S, Rosenquist R and Vilpo J: More extensive genetic alterations in unmutated than in hypermutated cases of chronic lymphocytic leukaemia. Genes Chromosomes Cancer 37: 417-420,2003.
54. Jarosova M, Jedlickova K, Holzerova M, Urbanova R, Papajik T, Raida L, Pikalova Z, Lakoma I, Prekopova I, Kropackova J and Indrak K: Contribution of comparative genomic hybridization and fluorescence in situ hybridization to the detection of chromosomal abnormalities in B-cell chronic lymphocytic leukemia. Onkologie 24: 60-65,2001.
55. Odero MD, Soto JL, Matutes E, Martin-Subero JI, Zudaire I, Rao PH, Cigudosa JC, Ardanaz MT, Chaganti RSK, Perucho M and Calasanz MJ: Comparative genomic hybridization and amplotyping by arbitrarily primed PCR in stage A B-CLL. Cancer Genet Cytogenet 130: 8-13,2001.
56. Döhner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, Döhner K, Bentz M and Lichter P: Genomic aberrations and survival in chronic lymphocytic Leukemia. N Engl J Med 343: 1910-1916, 2000.
57. Stilgenbauer S, Bullinger I, Benner A, Wildenberger K, Bentz M, Döhner K, Ho AD, Lichter P and Döhner H: Incidence and clinical significance of 5q deletion in B cell chronic lymphocytic leukemia. Leukemia 13: 1331-1334,1999.
58. O'Connor SJM, Su'ut L, Morgan GJ and Jack AS: The relationship between typical and atypical chronic lymphocytic leukemia. A comparative genomic hybridization-based study. Am J Clin Pathol 114:448-458,2000.
59. Andersen CL, Gruszka-Westwood A, Östergaard M, Koch J, Jacobsen E, Kjeldsen E and Nielsen B: A narrow deletion of 7q is common to HCL, and SMZL, but not CLE. Eur J Haematol 72: 390-402, 2004.
60. Schwaenen C, Nessling M, Wessendorf S, Salvi T, Wrobel G, Radlwimmer B, Kestler HA, Haslinger C, Stilgenbauer S, Döhner H, Bentz M and Lichter P: Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci USA 101: 1039-1044, 2004.
61. Summersgill B, Thornton P, Atkinson S, Matutes E, Shipley J, Catovsky D, Houlston RS and Yuille MR: Chromosomal imbalances in familial chronic lymphocytic leukemia: a comparative genomic hybridization analysis. Leukemia 16: 1229-1232,2002.
62. Costa D, Queralt R, Aymerich M, Carrion A, Rozman M, Vallespi T, Colomer D, Nomdedeu B, Montserrat E and Campo E: High levels of chromosomal imbalances in typical small-cell variants of T-cell prolymphocytic leukemia. Cancer Genet Cytogenet 147: 36-43, 2003.
63. Odero MD, Matutes E, Valaganon M, Cigudosa JC, Bengoechea E and Calasanz MJ: Complex karyotype in one patient with small cell variant of T-prolymphocytic leukemia. Analysis by G-banding and comparative genomic hybridization. Haematologica Internet 2001/3.
64. Soulier P, Pierron G, Vecchione D, Garand R, Brizard F, Sigaux F, Stern MH and Auria A: A complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia. Genes Chromosomes Cancer 31: 248-254, 2001.
65. Efferth T, Verdorfer I, Miyachi H, Sauerbrey A, Drexler HG, Chitambar CR, Haber M and Gebhart E: Genomic imbalances in drug-resistant T-cell acute lymphoblastic CEM leukaemia cell lines. Blood Cells Mol Dis 29: 1-13, 2002.
66. Aalto Y, Nordling S, Kivioja AH, Karaharju E, Elomaa I and Knuutila S: Among numerous DNA copy number changes, losses of chromosome 13 are highly recurrent in plasmacytoma. Genes Chromosomes Cancer 25: 104-107, 1999.
67. Avet-Loiseau H, Andree-Ashley LE, Moore D II, Mellerin MP, Feusner J, Bataille R and Pallavicini MG: Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization. Genes Chromosomes Cancer 19: 124-133, 1997.
68. Avet-Loiseau H and Bataille R: Detection of non-random chromosomal changes in multiple myeloma by comparative genomic hybrdization. Blood 92: 2997-2998, 1998.
69. Cigudosa JC, Rao PH, Calasanz NJ, Odero MD, Michaeli J, Jhanwar SC and Chaganti RSK: Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization. Blood 91: 3007-3010, 1998.
70. Gutierrez NC, Hernandez JM, Garcia JL, Canizo MC, Gonzalez M, Hernandez J, Gonzalez MB, Barcia Marcos MA and San Miguel JF: Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization. Leukemia 15: 840-845, 2001.
71. Gutierrez NC, Garcia JL, Hernandez JM, Lumbreras E, Castellanos M, Rasilio A, Mateo G, Hernandez JM, Perez S, Orfao A and San Miguel JF: Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma. Blood 104: 2661-2666, 2004.
72. + biastic tumor of the skin: cytogenetic observations and fürther evidence of an origin from : plasmocytoid dendritic cells. Eur J Dematol 14: 317-322, 2004.
73. Tchinda J, Volpert S, Kropff M, Berdel WE, Kienast J, Meinhardt F and Horst J: Frequent gains of the short arm of chromosome 9 in multiple myeloma with normal G-banded karyotype detected by comparative genomic hybridization. Am J Clin Pathol 122: 875-882, 2004.
74. + Hodgkin cells. Cancer Res 60: 549-552, 2000.
75. Franke S, Wlodarska I, Maes B, Vandenberghe P, Dealbie J, Hagemeijer A and De Wolf-Peeters C: Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances. Blood 97: 1845-1853,2001.
76. Joos S, Menz CK, Wrobel G, Siebert R, Gesk S, Ohl S, Mechtersheimer G, Trumper L, Möller P, Lichter P and Barth TFE: Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 99: 1381-1387,2002.
77. Chui DTY, Hammond D, Baird M, Shirld L, Jackson R and Jarrett RF: Classical Hodgkin lymphoma is associated with frequent gains of 17q. Genes Chromosomes Cancer 38: 126-136, 2003.
78. Oshima K, Ishiguro M, Ohgami A, Sugihara M, Haraoka S, Suzumiya J and Kikuchi M: Genetic analysis of sorted Hodgkin and Reed-Sternberg cells using comparative genomic hybridization. Int J Cancer 82: 250-255, 1999.
79. Oshima K, Haraoka S, Yoshioka S, Kawasaki C, Tutiya T, Suzumiya J and Kikuchi M: Chromosome 16q deletion and loss of E-cadherin expression in Hodgkin and Reed-Sternberg cells. Int J Cancer 92: 678-682, 2001.
80. Franke S, Wlodarska I, Maes B, Vandenberghe P, Achten R, Hagemeijer A and De Wolf-Peters C: Comparative genomic hybridization pattern distinguished T-cell/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin's lymphoma. Am J Pathol 161: 1861-1867, 2002.
81. Avet-Loiseau H, Vigier M, Moreau A, Mellerin MP, Gaillard F, Harousseau JL, Bataille R and Milpied N: Comparative genomic hybridization detects genomic abnormalities in 80% of follicular lymphomas. Br J Haematol 97: 119-122, 1997.
82. Bentz M, Werner CA, Döhner H, Joos S, Barth TFE, Siebert R, Schroder M, Stilgenbauer S, Fischer K, Möller P and Lichter P: High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. Blood 88: 1437-1444, 1996.
83. Goff LK, Neat MJ, Crawley CR, Jones L, Jones E, Lister TA and Gupta RK: The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma. Br J Haematol 111:518-625, 2000.
84. Hough RE, Goepel JR, Alcock HE, Hancock BW, Lorigan PC and Hammond DW: Copy number gain at 12ql2-14 may be important in the transformation from follicular lymphoma to diffuse large B cell lymphoma. Br J Cancer 84: 499-503, 2001.
85. Viardot A, Martin-Subero JI, Siebert R, Harder S, Gesk S, Bentz M and Schlegelberger B: Detection of secondary genetic aberrations in follicla center cell derived lymphomas: assessment of the reliability of comparative genomic hybridization and standard chromosome analysis. Leukemia 15: 177-183,2001.
86. Viardot A, Möller P, Högel J, Werner K, Mechtersheimer G, Ho AD, Ott G, Barth TFE, Siebert R, Gesk S, Schlegelberger B, Döhner H and Bentz M: Clinicopathologic correlations of genomic gains and losses in follicular lymphoma. J Clin Oncol 20: 4523-4530, 2002.
87. Monni O, Joensuu H, Franssila K and Knuutila S: DNA copy number changes in diffuse large B-cell lymphoma - a comparative genomic hybridization study. Blood 87: 5269-5278, 1996.
88. + anaplastic large cell lymphoma. Genes Chromosomes Cancer 37: 176-185,2003.
89. Kärnan S, Tagawa H, Suzuki R, Suguro M, Yamaguchi M, Okamoto M, Morishima Y, Nakamura S and Seto M: Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridisation. Genes Chromosomes Cancer 39: 77-81, 2004.
90. Zhang X, Kärnan S, Tagawa H, Suzuki R, Tsuzuki S, Hosokawa Y, Morishima Y, Nakamura S and Seto M: Comparison of genetic aberrations in CD10(+) diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tiussue-fluorescence in situ hybridization. Cancer Sci 95: 809-814, 2004.
91. Berglund M, Enblad G, Flordal E, Lui WO, Backlin C, Thunberg U, Sundström C, Roos G, Allander SV, Erlanson M, Rosenquist R, Larsson C and Lagercrantz S: Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization. Mod Pathol 15: 807-816, 2002.
92. Martinez-Climent JA, Alizadeh AA, Segraves R, Blesa D, Rubio-Moscardo F, Albertson DG, Garcia-Conde J, Dyer MJS, Levy R, Pinkel D and Lossos IS: Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogenous set of DNA copy number and gene expression alterations. Blood 101: 3109-3117, 2003.
93. Palanisamy N, Abou-Elella AA, Chaganti SR, Houldsworth J, Offit K, Louie DC, Terayu-Feldstein J, Cigudosa JC, Rao PH, Sanger WG, Weisenburger DD and Chaganti RSK: Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma. Genes Chromosomes Cancer 33: 114-122, 2002.
94. Monni O, Joensuu H, Franssila K, Klefstrom J, Alitalo K and Knuutila S: BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood 90:1168-1174,1997.
95. Rao PH, Houldsworth J, Dyomina K, Parsa NZ, Cigudosa JC, Louie DC, Popplewell LL, Offit K, Jhanwar SC and Chaganti RSK: Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 92: 234-240, 1998.
96. Wessendorf S, Schwaenen C, Kohlhammer H, Kienle D, Wrobel G, Barth TF, Nessling M, Möller P, Döhner H, Lichter P and Bentz M: Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization. Oncogene 22: 1425-1429, 2003.
97. Bea S, Ribas M, Hernandez JM, Bosch F, Pinyol M, Hernandez L, Garcia JL, Flores T, Gonzalez M, Lopez- Guillermo A, Piris MA, Cardesa A, Montserrat E, Miro R and Campo E: Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood 93: 4365-4374, 1999.
98. Monni O, Oinonen R, Elonen E, Franssila K, Teerenhovi L, Joensuu H and Knuutiula S: Gain of 3q and deletion of lq22 are frequent aberrations in mantle cell lymphoma. Genes Chromosomes Cancer 21: 298-307, 1998.
99. Bentz M, Plesch A, Bullinger L, Stilgenbauer S, Ott G, Muller- Hermelink HK, Baudis M, Barth TFE, Möller P, Lichter P and Dolmer H: t(11;14)-positive mantle cell lymphomas exhibit complex karytypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 27: 285-294, 2000.
100. Allen JE, Hough RE, Goepel JR, Bottomley S, Wilson GA, Alcock HE, Baird M, Lorigan PC, Vandenberghe EA and Hancock BW: Identification of novel regions of amplification within mantle cell lymphoma DNA by comparative genomic hybridization. Br J Haematol 116: 291-298, 2002.
101. Kohlhammer H, Schwaenen C, Wessendorf S, Holzmann K, Kestler HA, Kienle D, Barth TFE, Möller P, Ott G, Kalla J, Radlwimmer B, Pscherer A, Stilgenbauer S, Dolmer H, Lichter P and Bentz M: Genomic DNA-chip hybridization in t(11;14)- positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. Blood 104: 795-801, 2004.
102. Tagawa H, Kärnan S, Suzuki R, Matsuo K, Zhang X, Ota A, Morishima Y, Nakamura S and Seto M: Genome-wide arraybased CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 24: 1348-1358,2005.
103. De Leeuw RJ, Davies JJ, Rosenwald A, Bebb G, Gascoyne RD, Dyer MJS, Staudt LM, Martinez-Climent JA and Lam WL: Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. Hum Mol Genet 13: 1827-1837, 2004.
104. Flordal E, Berglund M, Rosenquist R, Erlanson M, Enblad G, Roos G, Larsson C and Lagercrantz S: Clonal development of a blastoid mantle cell lymphoma studied with comparative genomic hybridization. Cancer Genet Cvtogenet 139: 38-43, 2002.
105. Zunino A, Viaggi S, Ottaggio L, Fronza G, Schenone A, Roncella S and Abbondandolo A: Chromosomal aberrations evaluated by CGH, FISH, and GTG-banding in a case of A1DSrelated Burkitt's lymphoma. Haematologia 85: 250-255, 2000.
106. Garcia JL, Hernandez JM, Gutierrez NC, Flores T, Gonzalez D, Calasanz MJ, Martinez-Climent JA, Oiris MA, Lopez-Capitan C, Gonzalez MB, Odero MD and San Miguel JF: Abnormalities on lq and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study. Leukemia 17: 2016-2024, 2003.
107. Barth TFE, Muller S, Pawlita M, Siebert R, Rother JU, Mechtersheimer G, Kitinya J, Bentz M and Möller P: Homogenous immunophenotype and paucity of secondary genomic aberrations are distinct features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with myc rearrangement. J Pathol 203: 940-945, 2004.
108. Autio K, Aalto Y, Franssila K, Elonen E, Joensuu H and Knuutila S: Low number of DNA copy number changes in small lymphocytic lymphoma. Haematologica 83: 690-692, 1998.
109. + T-cell lymphoma. J Pathol 201: 421-429,2003.
110. Zettl A, Ott G, Makulik A, Katzenberger T, Starostik P, Eichler T, Puppe B, Bentz M, Muller-Hermelink HK and Chott A: Chromosomal gains at 9q characterize enteropathytypc T-cell lymphoma. Am J Pathol 161: 1635-1645,2002.
111. Renedo M, Martinez-Delgado B, Arranz E, Garcia MJ, Urioste M, Martinez-Ramirez A, Rivas C, Cigudosa JC and Benitez J: Chromosomal changes pattern and gene amplification in T cell non-Hodgkin's lymphomas. Leukemia 15: 1627-1632, 2001.
112. Andersen CL, Gruszka-Wesrwood A, Atkinson S, Matutes E, Catovsky D, Pedersen RK, Pedersen BB, Pulczynski S, Hokland P, Jacobsen EA and Koch J: Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization. Cancer Genet Cytogenet 156:122-128,2005.
113. Dierlamm J, Rosenberg C, Stul M, Pittaluga S, Wlodarska I, Michaux L, Dehaen M, Verhoef G, Thomas J, De Keiver W, Bakker-Schut T, Cassiman JJ, Raap AK, De Wolf-Peters C, van den Berghe H and Hagemeijer A: Characteristic pattern of chromosomal gains and losses in marginal zone B-cell lymphoma detected by comparative genomic hybridization. Leukemia 11:747-758, 1997.
114. Hernandez JM, Garcia JL, Gutierrez NC, Mollejo M, Martinez- Climent JA, Flores T, Gonzalez MB, Piris MA and San Miguel JF: Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization. Am J Pathol 158: 1843-1850,2001.
115. Boonstra R, Bosga-Bouwer A, van Imhoff GW, Krause V, Palmer M, Coupland RW, Dabbagh L, van den Berg E, van den Berg A and Poppema S: Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss of 7q31-q32. Mod Pathol 16: 1210-1217,2003.
116. Mao X, Lillington D, Child F, Russell-Jones R, Young B and Whittaker S: Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis. Genes Chromosomes Cancer 35: 144-155,2002. .
117. Hallerman C, Kaune KM, Siebert R, Vermeer MH, Tensen CP, Willemze R, Gunawan B, Bertsch HP and Neumann C: Chromo-somal aberration patterns differ in subtypes of primary cutaneous B cell lymphomas. J Invest Dermatol 122: 1495-1502, 2004.
118. Fischer TC, Gellrich S, Muche JM, Sherev T, Audring H, Neitzel H, Walden P, Sterry W and Tönnies H: Genomic aberrations and survival in cutaneous T cell lymphomas. J Invest Dermatol 122: 579-586, 2004.
119. Karenko L, Kahkonen M, Hyytinen ER, Lindlof M and Ranki A: Notable losses at specific regions of chromosomes lOq and 13q in the Sezary syndrome detected by comparative genomic hybridization. J Invest Dermatol 112: 392-395, 1999.
120. Mao X, Lillington D, Scarisbrick JJ, Mitchell T, Czepulkowski B, Russel-Jones R, Young B and Whittaker SJ: Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sezary syndrome and mycosis fungoides. Br J Dermatol 147: 464-475, 2002.
121. Mao X, Lillington D, Czepulkowski B, Russel-Jones R, Young B and Whittaker SJ: Molecular cytogenetic characterization of Sezary syndrome. Genes Chromosomes Cancer 36: 250-260, 2003.
122. Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD and Whittaker SJ: Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. Blood 101:1513-1519,2003.
123. Barth TFE, Bentz M, Leithäuser F, Stilgenbauer S, Siebert R, Schlotter M, Schlenk RF, Dohner H and Möller P: Molecularcytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract. Genes Chromosomes Cancer 31: 316-325, 2001.
124. Chan WY, Wong N, Chan ABW, Chow JHS and Lee JCK: Consistent copy number gain in chromosome 12 in primary diffuse large cell lymphomas of the stomach. Am J Pathol 152: 11-16,1998.
125. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf Peters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E and Warnke RA: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84: 1361-1392, 1994.
126. Bentz M, Barth TFE, Brüderlein S, Bock D, Schwerer MJ, Baudis M, Joos S, Viardot A, Feller AC, Müller-Hermelink HK, Lichter P, Döhner H and Möller P: Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer 30: 393-401, 2001.
127. Rickert CH, Dockhor-Dworniczak B, Simon R and Paulus W: Chromosomal imbalances in primary lymphomas of the central nervous system. Am J Pathol 155: 1445-1451, 1999.
128. Weber T, Weber RG, Kaulich K, Actor B, Meyer-Puttlitz B, Lampel S, Büschges R, Weigel R, Deckert-Schluter M, Schmiedek P, Reifenberger G and Lichter P: Characteristic chromosomal imbalances in primary central nervous system lymphomas of the diffuse large B-cell type. Brain Pathol 10: 73-84, 2000.
129. Harada K, Nishizaki T, Kubota H, Harada K, Suzuki M and Sasaki K: Distinct primary central nervous system lymphoma defined by comparative genomic hybridization and laser scanning cytometry. Cancer Genet Cytogenet 125: 147-150, 2001.
130. Boonstra R, Koning A, Mastik M, van den Berg A and Poppema S: Analysis of chromosomal copy number changes and oncoprotein expression in primary central nervous system lymphomas: frequent loss of chromosome arm 6q. Virchows Arch 443: 164-169, 2003.
131. Ness GO, Lybaek H, Arnes J and Rödahl E: Chromosomal imbalances in lymphoid tumors of the orbit. Invest Ophthalmol Vis Sci 43: 9-14, 2002.
132. Matteucci C, Galieni P, Leoncini L, Lazzi S, Lauria F, Polito E, Martelli MF and Mecucci C: Typical genomic imbalances in primary MALT lymphoma of the orbit. J Pathol 200: 656-660, 2003.
133. Siu LLP, Wong KF, Chan JKC and Kwong YL: Comparative genomic hybridization analysis of natural killer cell lymphoma/ leukemia. Recognition of consistent patterns of genetic alterations. Am J Pathol 155: 1419-1425, 1999.
134. Ko YH, Choi KE, Han JH, Kim JM and Ree HJ: Comparative genomic hybridization study of nasal-type NK/T-cell lymphoma. Cytometry 46: 85-91,2001.
135. Naumann S, Reutzel D, Speicher M and Decker HJ: Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization. Leukemia Res 25: 313-322, 2001.
136. Ulger C, Toruner GA, Alkan M, Mohammed M, Damani S, Kang J, Galante A, Aviv H, Soteropoulos P, Tolias PP, Schwalb MN and Dermody JJ: Comprehensive genome-wide comparison of DNA and RNA level scan using microarray technology for identification of candidate cancer-related genes in the HL-60 cell line. Cancer Genet Cytogenet 147: 28-35, 2003.
137. Tosi S, Giudici G, Rambaldi A, Scherer SW, Bray-Ward P, Dirscherl L, Biondi A and Kearney L: Characterization of the human myeloid leukemia-derived cell line GF-D8 by multiplex fluorescence in situ hybridization, subtelomeric probes, and comparative genomic hybridization. Genes Chromosomes Cancer 24:213-221, 1999.
138. Alvarez S, MacGrogan D, Calasanz MJ, Nimer SD and Jhanwar SC: Frequent gain of chromosome 19 in megakaryoblastic leukemias detected by comparative genomic hybridization. Genes Chromosomes Cancer 32: 285-293, 2001.
139. Cottier M, Tchirkov A, Perissel B, Giollant L and Vago P: Cytogenetic characterization of seven human cancer cell lines by combining G-and R-banding, M-FISH, CGH, and chromosomeand locus-specific FISH. Int J Mol Med 14: 483-495, 2004.
140. Lindbjerg Andersen C, Östergaard M, Nielsen B, Pedersen B and Koch J: Characterization of three hairy cell leukemiaderived cell lines (ESKOL, JOK-1, and Hair-M) by multiplex- FISH, comparative genomic hybridization, FISH, PRINS, and dideoxyPRINS. Cytogenet Cell Genet 90: 30-39, 2000.
141. Joos S, Granzow M, Holtgreve-Grez H, Siebert R, Harder L, Martin-Subero JI, Wolf J, Adamowicz M, Barth TFE, Lichter P and Jauch A: Hodgkin's lymphoma cell lines are characterized by frequent aberrations in chromoosmes 2p and 9p including REL and JAK2. Int J Cancer 103: 489-495, 2003.
142. + anaplastic large cell lymphoma cell lines. Cancer Genet Cytogenet 138:95-101,2002.
143. Strefford JC, Foot NJ, Chaplin T, Neat MJ, Oliver RTD, Young BD and Jones LK: The characterization of the lymphoma cell line U937, using comparative genomic hybridization and multiplex-FlSH. Cytogenet Cell Genet 94: 9-14, 2001.
144. Matteucci C, La Starza R, Crescenzi B, Falzetti D, Romoli S, Emiliani C, Orlacchio A, Marynen P, Martelli M and Mecucci C: Interpretation of the complex karyotype and identification of a new 6p amplicon by integrated comparative genomic hybridization and fluorescence in situ hybridization on the U937-I cell line. Cancer Genet Cytogenet 135: 28-34, 2002.
145. Carlson KM, Gruber A, Liliemark E, Larsson R and Nordenskjold M: Characterization of drug-resistant cell lines by comparative genomic hybridization. Cancer Genet Cytogenet 111:32-36,1999.
146. Efferth T, Miyachi H, Drexler HG and Gebhart E: Methyladenosine phosphorylase as target for chemoselective treatment of T-cell acute lymphoblastic leukemic cells. Blood Cells Mol Dis 28: 47-56, 2002.
147. Mänsson E, Flordal E, Liliemark J, Spasokoukotskaja T, Elford H, Lagercrantz S, Eriksson S and Albertioni F: Downregulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased nucleotide reductase activity contributes to fludarabine resistance. Biochem Pharmacol 65: 237-247, 2003.
148. Shimizu H, Fukuda T, Ghazizadeh M, Nagashima M, Kawanami O and Suzuki T: Molecular cytogenetic characterization of drug-resistant leukemia cell lines by comparative genomic hybridization and fluorescence in situ hybridization. Jpn J Cancer Res 93: 902-910, 2002.